Pharmaceutical

Subscribe

Jeffrey Kindler, the chief executive of the world''s largest drug maker Pfizer Inc., continued to clean house with the announcement late Sunday that the company''s research and development chief and

Britain''s government competition watchdog began an investigation into the supply of medicines across the country after Pfizer Inc. signed a deal to sell its prescription drugs through a single wholesaler,

Procter & Gamble Co. said it is cutting more than half of the work force at its cosmetics plant in Ireland and is shifting some of its operations to Poland

The Associated Press reports that drug maker Bristol-Myers Squibb Co. has purchased an 89-acre site to build a new plant for manufacturing biological compounds.The company said the new Devens, Mass.

Swiss pharmaceutical company Novartis AG announced its plans for a US$100 million (euro78 million) integrated research and development center in Shanghai that will initially focus on cancers prevalent in China,

VVF Ltd. issued a letter of intent to buy the soon-to-be-closed Colgate Palmolive plant in Kansas City, Kan., and all its equipment for $12 million, according to bizjournals.com. VVF plans

Teva Pharmaceutical Industries Ltd., the world''s largest generic drugmaker, said it will close a plant in Puerto Rico as part of an reorganization related to its acquisition of Ivax Corp.

According to the Associated Press, Archer Daniels Midland Co. must pay $1.35 million under a settlement with the U.S. Environmental Protection Agency resolving allegations that it violated federal clean air

A New Jersey judge has dismissed about 50 Vioxx-related lawsuits against Merck & Co. filed in state court by British citizens, saying the cases should be heard in Britain, the

Fort Worth plaintiffs'' attorney John David Hart and other Texas lawyers will be making their way to the courthouse in the next few days to file additional Vioxx lawsuits before